Johnson & Johnson (JNJ)
Johnson & Johnson is an American multinational corporation that operates in the healthcare, consumer goods, and pharmaceutical industries. It is known for its consumer products, such as Band-Aid and Tylenol, as well as its pharmaceutical products and medical devices. Johnson & Johnson has a strong presence in the global market and is headquartered in New Brunswick, New Jersey.
Company Info
US4781601046
478160104
Sep 24, 1944
Highlights
$373.28B
$5.95
25.65
0.92
$87.70B
$60.74B
$31.96B
$140.91 - $168.85
$175.98
0.78%
3.20
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Johnson & Johnson, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Johnson & Johnson had a return of 0.64% year-to-date (YTD) and 6.15% in the last 12 months. Over the past 10 years, Johnson & Johnson had an annualized return of 6.50%, while the S&P 500 had an annualized return of 11.16%, indicating that Johnson & Johnson did not perform as well as the benchmark.
JNJ
0.64%
-6.66%
1.24%
6.15%
5.59%
6.50%
^GSPC (Benchmark)
23.62%
0.54%
11.19%
30.63%
13.61%
11.16%
Monthly Returns
The table below presents the monthly returns of JNJ, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 1.38% | 2.33% | -1.98% | -8.60% | 2.26% | -0.35% | 8.00% | 5.87% | -2.29% | -1.36% | 0.64% | ||
| 2023 | -7.49% | -5.54% | 1.14% | 5.61% | -4.56% | 6.75% | 1.21% | -2.79% | -3.67% | -4.76% | 5.10% | 1.34% | -8.58% |
| 2022 | 0.71% | -3.87% | 7.69% | 1.82% | 0.12% | -1.13% | -1.68% | -6.93% | 1.25% | 6.49% | 2.98% | -0.76% | 5.97% |
| 2021 | 3.65% | -2.26% | 3.72% | -0.99% | 4.66% | -2.66% | 4.53% | 1.14% | -6.72% | 0.85% | -3.64% | 9.71% | 11.44% |
| 2020 | 2.06% | -9.09% | -2.49% | 14.42% | -0.17% | -5.46% | 3.65% | 5.95% | -2.95% | -7.91% | 6.25% | 8.78% | 10.82% |
| 2019 | 3.12% | 3.36% | 2.31% | 1.01% | -6.48% | 6.20% | -6.50% | -0.69% | 0.79% | 2.06% | 4.85% | 6.10% | 16.22% |
| 2018 | -1.10% | -5.41% | -1.33% | -1.30% | -4.73% | 1.44% | 9.21% | 2.31% | 2.58% | 1.32% | 5.60% | -12.15% | -5.13% |
| 2017 | -1.70% | 8.63% | 1.91% | -0.87% | 4.56% | 3.15% | 0.33% | 0.37% | -1.78% | 7.23% | 0.55% | 0.28% | 24.43% |
| 2016 | 1.67% | 1.47% | 2.84% | 3.59% | 1.26% | 7.64% | 3.24% | -4.07% | -1.01% | -1.81% | -3.38% | 3.51% | 15.33% |
| 2015 | -4.24% | 3.08% | -1.86% | -1.39% | 1.68% | -2.68% | 2.82% | -5.50% | -0.67% | 8.23% | 0.95% | 1.46% | 1.14% |
| 2014 | -3.41% | 4.88% | 6.63% | 3.12% | 0.87% | 3.11% | -4.33% | 4.34% | 2.76% | 1.12% | 1.09% | -3.40% | 17.34% |
| 2013 | 5.45% | 3.79% | 7.12% | 4.54% | -0.49% | 2.00% | 8.90% | -6.89% | 0.32% | 6.83% | 2.93% | -3.24% | 34.62% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of JNJ is 52, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Johnson & Johnson (JNJ) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Johnson & Johnson provided a 3.15% dividend yield over the last twelve months, with an annual payout of $4.86 per share. The company has been increasing its dividends for 27 consecutive years, earning it the status of a dividend aristocrat.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $4.86 | $4.70 | $4.45 | $4.19 | $3.98 | $3.75 | $3.54 | $3.32 | $3.15 | $2.95 | $2.76 | $2.59 |
Dividend yield | 3.15% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% | 2.83% |
Monthly Dividends
The table displays the monthly dividend distributions for Johnson & Johnson. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $1.19 | $0.00 | $0.00 | $1.24 | $0.00 | $0.00 | $1.24 | $0.00 | $0.00 | $0.00 | $3.67 | |
| 2023 | $0.00 | $1.13 | $0.00 | $0.00 | $1.19 | $0.00 | $0.00 | $1.19 | $0.00 | $0.00 | $1.19 | $0.00 | $4.70 |
| 2022 | $0.00 | $1.06 | $0.00 | $0.00 | $1.13 | $0.00 | $0.00 | $1.13 | $0.00 | $0.00 | $1.13 | $0.00 | $4.45 |
| 2021 | $0.00 | $1.01 | $0.00 | $0.00 | $1.06 | $0.00 | $0.00 | $1.06 | $0.00 | $0.00 | $1.06 | $0.00 | $4.19 |
| 2020 | $0.00 | $0.95 | $0.00 | $0.00 | $1.01 | $0.00 | $0.00 | $1.01 | $0.00 | $0.00 | $1.01 | $0.00 | $3.98 |
| 2019 | $0.00 | $0.90 | $0.00 | $0.00 | $0.95 | $0.00 | $0.00 | $0.95 | $0.00 | $0.00 | $0.95 | $0.00 | $3.75 |
| 2018 | $0.00 | $0.84 | $0.00 | $0.00 | $0.90 | $0.00 | $0.00 | $0.90 | $0.00 | $0.00 | $0.90 | $0.00 | $3.54 |
| 2017 | $0.00 | $0.80 | $0.00 | $0.00 | $0.84 | $0.00 | $0.00 | $0.84 | $0.00 | $0.00 | $0.84 | $0.00 | $3.32 |
| 2016 | $0.00 | $0.75 | $0.00 | $0.00 | $0.80 | $0.00 | $0.00 | $0.80 | $0.00 | $0.00 | $0.80 | $0.00 | $3.15 |
| 2015 | $0.00 | $0.70 | $0.00 | $0.00 | $0.75 | $0.00 | $0.00 | $0.75 | $0.00 | $0.00 | $0.75 | $0.00 | $2.95 |
| 2014 | $0.00 | $0.66 | $0.00 | $0.00 | $0.70 | $0.00 | $0.00 | $0.70 | $0.00 | $0.00 | $0.70 | $0.00 | $2.76 |
| 2013 | $0.61 | $0.00 | $0.00 | $0.66 | $0.00 | $0.00 | $0.66 | $0.00 | $0.00 | $0.66 | $0.00 | $2.59 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Johnson & Johnson. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Johnson & Johnson was 38.78%, occurring on Aug 11, 1993. Recovery took 399 trading sessions.
The current Johnson & Johnson drawdown is 10.90%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -38.78% | Jan 9, 1992 | 403 | Aug 11, 1993 | 399 | Mar 10, 1995 | 802 |
| -38.35% | Aug 26, 1987 | 38 | Oct 19, 1987 | 415 | Jun 9, 1989 | 453 |
| -36.51% | Nov 17, 1999 | 76 | Mar 7, 2000 | 324 | Jun 19, 2001 | 400 |
| -35.88% | Mar 20, 2002 | 85 | Jul 19, 2002 | 608 | Dec 16, 2004 | 693 |
| -34.4% | Sep 9, 2008 | 125 | Mar 9, 2009 | 549 | May 11, 2011 | 674 |
Volatility
Volatility Chart
The current Johnson & Johnson volatility is 4.13%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Johnson & Johnson compared to its peers in the Drug Manufacturers - General industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for JNJ in comparison to other companies of the Drug Manufacturers - General industry. Currently, JNJ has a PE value of 25.7. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for JNJ in comparison to other companies of the Drug Manufacturers - General industry. Currently, JNJ has a PEG value of 0.9. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Johnson & Johnson.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |